Advice
On 15 October 2025, exenatide 2mg powder and solvent for prolonged-release suspension for injection (Bydureon®) was discontinued.
Medicine details
- Medicine name:
- exenatide (Bydureon)
- SMC ID:
- 748/11
- Indication:
Treatment of type 2 diabetes mellitus.
- Pharmaceutical company
- Eli Lilly and Company Ltd
- BNF chapter
- Endocrine system
- Submission type
- Full
- Status
- Withdrawn
- Date advice published
- 16 January 2012
Additional notes
On 15 October 2025, exenatide 2mg powder and solvent for prolonged-release suspension for injection (Bydureon®) was discontinued.